According to a recent research, aspirin may help prevent and cure colorectal cancer while also boosting the immune system.....KINDLY READ THE FULL STORY HERE▶
Aspirin is a medicine commonly used to relieve pain and reduce inflammation. But a new study suggests that aspirin may also play a role in preventing and treating colorectal cancer, while strengthening the immune system. This research, published in the journal Cancer, shows that people with colorectal cancer who are taking aspirin have less spread of the disease to the lymph nodes than those who do not. In addition, aspirin appears to help the immune system identify and remove cancer cells.
Relationship between aspirin and colorectal cancer
Colorectal cancer is one of the most common cancers in the world. Colorectal cancer rates in people under 50 are increasing by 2% per year, making this disease increasingly worrying.
Previous studies have already linked aspirin use to the results of colorecta l cancer, but the precise mechanism of the effect of the medicine on the disease has remained unclear. This new research provides new insight into this mechanism. Results suggest that aspirin can adjust the function of the immune system to make it more vigilant about cancer cells and eliminate them more effectively.
Aspirin has anti-inflammatory effects similar to non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that aspirin can adjust the function of the immune system to make it more vigilant with cancer cells and eliminate them more effectively. However, many questions remain about the link between the use of aspirin and colorectal cancer, in particular which can benefit from the medicine. Low-dose aspirin has a low risk of severe bleeding, limiting its recommendation as a tool for preventing colorectal cancer for the whole population. Further research is needed to better understand the potential benefits of aspirin and to identify the groups of people who can benefit most from it.
How aspirin can fight colorectal cancer
The study analysed tissue samples from 238 people with colorectal cancer who underwent surgery between 2015 and 2019. Results showed that patients who took aspirin had less spread of cancer to the lymph nodes. In addition, the samples revealed that aspirin appeared to have an “immune surveillance” effect, with increased infiltration of immune cells into the tumour.
The research team also treated colorectal cancer cells with aspirin and found that these cells appeared to have better immune function. These findings suggest that aspirin can help the body better recognise cancer cells and alert other defence cells to their presence.
Aspirin appears to improve the ability of cells to alert other tumour-associated proteins to other defence cells. This discovery opens up a potential new pathway to improve the results of colorectal cancer through aspirin. Previous research has already suggested that aspirin can limit the spread of cancer by blocking platelet aggregation, preventing tumour cells from moving through the blood.
Reducing the risk of colorectal cancer
In addition to the use of aspirin, there are other ways to reduce the risk of colorectal cancer. A balanced diet rich in fiber, fruit and vegetables can help maintain a healthy digestive system. Regular exercise and the maintenance of a healthy weight are also important to reduce the risk of developing this disease. In addition, regular screening is recommended, such as colonoscopy, especially from the age of 45. These screenings make it possible to detect the early signs of colorectal cancer and to intervene quickly.
Symptoms of colorectal cancer
It is essential to know the symptoms of colorectal cancer, as the rates of this disease increase in young people. Signs to be monitored include a change in bowel habits, diarrhoea, constipation, feeling that the gut is not completely emptied, blood in the stools, persistent abdominal pain and unexplained weight loss. If you notice any of these symptoms, it is important to consult a doctor and ask for a diagnostic colonoscopy to determine the cause of these abnormal symptoms.
Daily aspirin can play a role in the prevention and treatment of colorectal cancer. This study suggests that aspirin helps reduce the spread of cancer to the lymph nodes and strengthens the immune system by helping the body to detect and remove cancer cells. However, further research is needed to better understand the mechanisms of action of aspirin in colorectal cancer and to identify the groups of people who could benefit most from this treatment.
It is important to remember that aspirin presents potential risks, including serious bleeding. Therefore, the use of aspirin for colorectal cancer prevention should be assessed on a case-by-case basis by a healthcare professional. In addition to the use of aspirin, adopting a healthy lifestyle with a balanced diet, regular exercise and regular screening can help reduce the risk of colorectal cancer.
The study on the use of aspirin in colorectal cancer offers a new perspective on the prevention and treatment of aspirin. However, it is important to consult a doctor to assess the potential benefits and risks of using aspirin in each individual case.